Lobbying client · LD-2 disclosures
Leukemia & Lymphoma Society
New York
27 filings from 2 registrants · 2008–2015 · latest filed Jan 8, 2016
Reported on its behalf
$670K
every LD-2 on file
Its own filed spend
$0
lobbying for itself
Fees to outside firms
$670K
across every firm on file
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Health Issues
HCR
15 filings
$610K on those filings
Budget/Appropriations
BUD
13 filings
$80K on those filings
Medical/Disease Research/Clinical Labs
Bills named in the filings
The 15 most-cited of 22 bill references, extracted from the activity descriptions.
Who did the lobbying
Every lobbyist named on this client's filings.
- Harry Anastasios Sporidis Polsinelli PCCovered position: LA, Reps. E.C. Shaw, M. Bilirakis; Sr. LA, Rep. J. Greenwood14 filingsthrough 2015
- Tim Perrin Polsinelli PCCovered position: Washington Fellow, Rep. Floyd Spence13 filingsthrough 2015
- Elizabeth Goss Turner & Goss LLP13 filingsthrough 2012
- Stephanie Marie Kriston Polsinelli PC11 filingsthrough 2015
The filings
The 20 most recent of 27 filings. Every figure above is built from these records.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: leukemia-lymphoma-society.